Clinical psychopharmacology for neurologists : a practical guide /: a practical guide. ([2018])
- Record Type:
- Book
- Title:
- Clinical psychopharmacology for neurologists : a practical guide /: a practical guide. ([2018])
- Main Title:
- Clinical psychopharmacology for neurologists : a practical guide
- Further Information:
- Note: George T. Grossberg, Laurence J. Kinsella, editors.
- Editors:
- Grossberg, George T
Kinsella, Laurence J - Contents:
- Intro; Foreword; Contents; Contributors; Chapter 1: Psychopharmacology for Neurologists; Clinical Vignette; Discussion; Scope of this Book; References; Chapter 2: General Principles of Psychopharmacology; Pharmacokinetics Vs. Pharmacodynamics; Pharmacokinetics; Pharmacodynamics; Drug Interactions; FDA Drug Approval; Off-Label Use; DEA Schedules of Drugs; Common Side Effects of Psychotropic Drugs and How to Manage Them; Neurotransmitter Systems; Specific Side Effects of Newer Psychotropic Drugs; Weight Gain; Sexual Dysfunction; Movement Disorders; Cardiovascular; Weight Loss; Hyponatremia. Cognitive ImpairmentSerum Glucose Alterations; Gastrointestinal Issues; Rash; What Is a Black Box Warning and Which Psychotropes Have One?; Drug Withdrawal/Discontinuation; Pregnant and Nursing Women: Special Considerations; Hepatic/Renal Insufficiency: Impact on Dosing; Renal Insufficiency; Hepatic Insufficiency; Laboratory Monitoring; Lithium Serum Levels; WBC for Clozapine and Carbamazepine; TCAs for Depression; Antipsychotics; Conclusion; References; Chapter 3: Special Considerations for the Elderly; Basic Principles of Geriatric Psycho-pharmacotherapy; Document Target Symptoms. Case StudyEnsure Close Collaboration Among Various Prescribers; Start One Medication at a Time; Start Low and Go Slow, But Go; Hepatic and Renal Considerations; Knowledge of Available Formulations; Knowledge of Drug-Drug Interactions; Assess Role of Gender, Lifestyle, Racial/Ethnic Differences in Drug MetabolismIntro; Foreword; Contents; Contributors; Chapter 1: Psychopharmacology for Neurologists; Clinical Vignette; Discussion; Scope of this Book; References; Chapter 2: General Principles of Psychopharmacology; Pharmacokinetics Vs. Pharmacodynamics; Pharmacokinetics; Pharmacodynamics; Drug Interactions; FDA Drug Approval; Off-Label Use; DEA Schedules of Drugs; Common Side Effects of Psychotropic Drugs and How to Manage Them; Neurotransmitter Systems; Specific Side Effects of Newer Psychotropic Drugs; Weight Gain; Sexual Dysfunction; Movement Disorders; Cardiovascular; Weight Loss; Hyponatremia. Cognitive ImpairmentSerum Glucose Alterations; Gastrointestinal Issues; Rash; What Is a Black Box Warning and Which Psychotropes Have One?; Drug Withdrawal/Discontinuation; Pregnant and Nursing Women: Special Considerations; Hepatic/Renal Insufficiency: Impact on Dosing; Renal Insufficiency; Hepatic Insufficiency; Laboratory Monitoring; Lithium Serum Levels; WBC for Clozapine and Carbamazepine; TCAs for Depression; Antipsychotics; Conclusion; References; Chapter 3: Special Considerations for the Elderly; Basic Principles of Geriatric Psycho-pharmacotherapy; Document Target Symptoms. Case StudyEnsure Close Collaboration Among Various Prescribers; Start One Medication at a Time; Start Low and Go Slow, But Go; Hepatic and Renal Considerations; Knowledge of Available Formulations; Knowledge of Drug-Drug Interactions; Assess Role of Gender, Lifestyle, Racial/Ethnic Differences in Drug Metabolism and Tolerance; Monitoring for Drug Response, Toxicity, and Interactions; Avoid Introducing a Drug to Treat the Side Effects of Another Drug; Case Study; Reducing Medication Burden; Periodic Drug Tapering and Discontinuation if Symptoms Are Well-Controlled; Patient and Family Education. Medication Cost/ReimbursementConclusion; References; Chapter 4: Antidepressants; Identifying Depression; Case Vignette: Part 1; Depression Screening; Subsyndromal Depression and Persistent Depressive Disorder; Case Vignette: Part 2; Subsyndromal Depression; Persistent Depressive Disorder (Dysthymia); Major Depressive Disorder; Case Vignette: Part 3; Diagnosing Major Depressive Disorder; Assessing Depression Severity; Completing the Assessment; Clinical Vignette: Part 3; Discussion; Prescribing an Antidepressant; Case Vignette: Part 4; Selecting an Antidepressant. Antidepressants for NeurologistsEvaluating and Adjusting Treatment; Case Vignette: Part 5; Evaluating Treatment Response; Continuing or Increasing the Antidepressant; Changing Antidepressants, if Not Effective; Goals and Duration of Treatment; Case Vignette: Part 6; Treat Residual Symptoms Fully; Duration of Treatment; Psychotherapy; Adverse Effects; Case Vignette: Part 7; Common Adverse Effects; Serious Adverse Effects; Other Adverse Effects; Discontinuation Syndrome; Neurological Illnesses; Epilepsy; Parkinson's Disease; Stroke; Multiple Sclerosis; Scales for Evaluating Treatment Response. … (more)
- Publisher Details:
- Cham, Switzerland : Springer
- Publication Date:
- 2018
- Extent:
- 1 online resource
- Subjects:
- 615.78
Medicine
Psychopharmacology
Drug interactions
MEDICAL -- Pharmacology
Dementia -- Treatment
Drug interactions
Psychopharmacology
Medical -- Psychiatry -- Psychopharmacology
Psychopharmacology
Neurology
Medical -- Neurology
Neurology & clinical neurophysiology
Electronic books - Languages:
- English
- ISBNs:
- 9783319746043
3319746049 - Related ISBNs:
- 9783319746029
3319746022 - Notes:
- Note: Print version record.
- Access Rights:
- Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
- Access Usage:
- Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD.DS.367099
- Ingest File:
- 01_343.xml